NEW YORK (GenomeWeb News) – Exiqon today said that it will divest its California-based CLIA lab, Oncotech, in an effort to "gain operational and infrastructural efficiencies and to free up human financial resources."

The Vedbaek, Denmark-based molecular diagnostics firm also said that as a consequence of the divestiture it would seek partners to co-develop and commercialize its miRNA-based diagnostic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcrips, and more.

After seeing Rich's image of the DNA double helix structure in 1973, James Watson called Rich and told him that it was the first time in 20 years he'd had a good night's sleep.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.